×
About 5,102 results

ALLMedicine™ Valvular Heart Disease Center

Research & Reviews  2,371 results

4D Flow CMR: The Final Frontier in Valvular Heart Disease?
https://doi.org/10.1016/j.jcmg.2021.03.011
JACC. Cardiovascular Imaging; Shah DJ

Apr 18th, 2021 - 4D Flow CMR: The Final Frontier in Valvular Heart Disease?|2021|Shah DJ,|

Athletes with valvular heart disease and competitive sports: a position statement of th...
https://doi.org/10.1093/eurjpc/zwab058
European Journal of Preventive Cardiology; van Buuren F, Gati S et. al.

Apr 13th, 2021 - This article provides an overview of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology on sports participation in individuals with valvular heart disease (VHD). The aim of these recommendat...

Recent progress toward clinical translation of tissue engineered heart valves.
https://doi.org/10.1016/j.cjca.2021.03.022
The Canadian Journal of Cardiology; Mirani B, Nejad SP et. al.

Apr 11th, 2021 - Surgical replacement remains the primary option to treat the rapidly growing number of patients with severe valvular heart disease. While current valve replacements - mechanical, bioprosthetic, and cryopreserved homografts - enhance survival and q...

Management of antithrombotic therapy in patients undergoing transcatheter aortic valve ...
https://doi.org/10.1093/eurheartj/ehab196
European Heart Journal; Ten Berg J, Sibbing D et. al.

Apr 6th, 2021 - Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic severe aortic stenosis, while the indication has recently broadened to younger patients at lower risk. Although thromboembolic and bleeding complication...

Numerical Biomechanics Models of the Interaction Between a Novel Transcatheter Mitral V...
https://doi.org/10.1177/1556984521999362
Innovations (Philadelphia, Pa.); Marom G, Plitman Mayo R et. al.

Apr 5th, 2021 - Mitral valve regurgitation (MR) is a common valvular heart disease where improper closing causes leakage. Currently, no transcatheter mitral valve device is commercially available. Raanani (co-author) and colleagues have previously proposed a uniq...

see more →

Guidelines  43 results

2019 HRS expert consensus statement on evaluation, risk stratification, and management ...
https://doi.org/10.1016/j.hrthm.2019.05.007
Heart Rhythm; Towbin JA, McKenna WJ et. al.

May 12th, 2019 - Arrhythmogenic cardiomyopathy (ACM) is an arrhythmogenic disorder of the myocardium not secondary to ischemic, hypertensive, or valvular heart disease. ACM incorporates a broad spectrum of genetic, systemic, infectious, and inflammatory disorders....

2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Opt...
https://doi.org/10.1016/j.athoracsur.2019.03.001
The Annals of Thoracic Surgery; Nishimura RA, O'Gara PT et. al.

Apr 23rd, 2019 - 2019 AATS/ACC/ASE/SCAI/STS Expert Consensus Systems of Care Document: A Proposal to Optimize Care for Patients With Valvular Heart Disease: A Joint Report of the American Association for Thoracic Surgery, American College of Cardiology, American S...

2017 ESC/EACTS Guidelines for the management of valvular heart disease.
https://doi.org/10.1093/ejcts/ezx324
European Journal of Cardio-thoracic Surgery : Official Jo... Falk V, Baumgartner H et. al.

Nov 20th, 2017 - 2017 ESC/EACTS Guidelines for the management of valvular heart disease.|2017|Falk V,Baumgartner H,Bax JJ,De Bonis M,Hamm C,|standards,standards,surgery,standards,

Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease ...
https://doi.org/10.1093/ejcts/ezx283
European Journal of Cardio-thoracic Surgery : Official Jo... Chambers JB, Prendergast B et. al.

Sep 6th, 2017 - Standards defining a 'Heart Valve Centre': ESC Working Group on Valvular Heart Disease and European Association for Cardiothoracic Surgery Viewpoint.|2017|Chambers JB,Prendergast B,Iung B,Rosenhek R,Zamorano JL,|organization & administration,stand...

ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality...
https://link.springer.com/content/pdf/10.1007%2Fs12350-017-1070-1.pdf
John U. Doherty

Aug 31st, 2017 - This document assesses a wide array of imaging modalities available to the clinician in the evaluation of patients with VHD. Presented here is a broad spectrum of clinical scenarios in such patients.

see more →

Clinicaltrials.gov  2,511 results

4D Flow CMR: The Final Frontier in Valvular Heart Disease?
https://doi.org/10.1016/j.jcmg.2021.03.011
JACC. Cardiovascular Imaging; Shah DJ

Apr 18th, 2021 - 4D Flow CMR: The Final Frontier in Valvular Heart Disease?|2021|Shah DJ,|

Athletes with valvular heart disease and competitive sports: a position statement of th...
https://doi.org/10.1093/eurjpc/zwab058
European Journal of Preventive Cardiology; van Buuren F, Gati S et. al.

Apr 13th, 2021 - This article provides an overview of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology on sports participation in individuals with valvular heart disease (VHD). The aim of these recommendat...

Recent progress toward clinical translation of tissue engineered heart valves.
https://doi.org/10.1016/j.cjca.2021.03.022
The Canadian Journal of Cardiology; Mirani B, Nejad SP et. al.

Apr 11th, 2021 - Surgical replacement remains the primary option to treat the rapidly growing number of patients with severe valvular heart disease. While current valve replacements - mechanical, bioprosthetic, and cryopreserved homografts - enhance survival and q...

Management of antithrombotic therapy in patients undergoing transcatheter aortic valve ...
https://doi.org/10.1093/eurheartj/ehab196
European Heart Journal; Ten Berg J, Sibbing D et. al.

Apr 6th, 2021 - Transcatheter aortic valve implantation (TAVI) is effective in older patients with symptomatic severe aortic stenosis, while the indication has recently broadened to younger patients at lower risk. Although thromboembolic and bleeding complication...

Numerical Biomechanics Models of the Interaction Between a Novel Transcatheter Mitral V...
https://doi.org/10.1177/1556984521999362
Innovations (Philadelphia, Pa.); Marom G, Plitman Mayo R et. al.

Apr 5th, 2021 - Mitral valve regurgitation (MR) is a common valvular heart disease where improper closing causes leakage. Currently, no transcatheter mitral valve device is commercially available. Raanani (co-author) and colleagues have previously proposed a uniq...

see more →

News  177 results

Valvular Heart Disease Clinical Practice Guidelines (ACC/AHA, 2021)
https://reference.medscape.com/viewarticle/944947

Jan 31st, 2021 - The American College of Cardiology (ACC) and American Heart Association (AHA) released their updated recommendations on managing valvular heart disease in December 2020.[1,2] Ten key messages are outlined below. Top 10 Take-Home Messages Valvular ...

ACC/AHA Valvular Heart Disease Update Backs Less-Invasive Approach
https://www.medscape.com/viewarticle/943526

Jan 3rd, 2021 - The latest iteration of the American College of Cardiology/American Heart Association (ACC/AHA) Guideline for the Management of Patients With Valvular Heart Disease emphasizes a less invasive approach to the management of patients with valvular he...

Valvular Disease and COVID-19 Are a Deadly Mix; Don't Delay Intervention
https://www.staging.medscape.com/viewarticle/940101

Oct 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Danny Dvir, MD, has a message for physicians who have patients with severe valvular heart disease who are deferring valve replacement or repair un...

Valvular Disease and COVID-19 Are a Deadly Mix; Don't Delay Intervention
https://www.medscape.com/viewarticle/940101

Oct 29th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. Danny Dvir, MD, has a message for physicians who have patients with severe valvular heart disease who are deferring valve replacement or repair un...

Heart Failure With Preserved Ejection Fraction Management: 5 Things to Know
https://www.medscape.com/viewarticle/938421_2

Oct 6th, 2020 - 2. Managing comorbid conditions is important. Although HFpEF is frequently characterized by its phenotypic heterogeneity, most patients also present with a host of other discrete, treatable medical comorbidities, such as hypertension, valvular hea...

see more →